MX2012006244A - Metodos y aparatos para segregacion de particulas, incluyendo segregacion y proliferacion de celulas fetales y celulas madre. - Google Patents
Metodos y aparatos para segregacion de particulas, incluyendo segregacion y proliferacion de celulas fetales y celulas madre.Info
- Publication number
- MX2012006244A MX2012006244A MX2012006244A MX2012006244A MX2012006244A MX 2012006244 A MX2012006244 A MX 2012006244A MX 2012006244 A MX2012006244 A MX 2012006244A MX 2012006244 A MX2012006244 A MX 2012006244A MX 2012006244 A MX2012006244 A MX 2012006244A
- Authority
- MX
- Mexico
- Prior art keywords
- cells
- conduit
- particles
- fluid
- cover
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims abstract description 328
- 238000000034 method Methods 0.000 title claims abstract description 79
- 238000005204 segregation Methods 0.000 title claims abstract description 34
- 230000001605 fetal effect Effects 0.000 title claims description 114
- 210000000130 stem cell Anatomy 0.000 title claims description 19
- 230000035755 proliferation Effects 0.000 title claims description 7
- 239000008280 blood Substances 0.000 claims abstract description 101
- 210000004369 blood Anatomy 0.000 claims abstract description 100
- 230000008774 maternal effect Effects 0.000 claims abstract description 49
- 210000004027 cell Anatomy 0.000 claims description 331
- 239000012530 fluid Substances 0.000 claims description 297
- 239000012528 membrane Substances 0.000 claims description 134
- 238000000926 separation method Methods 0.000 claims description 128
- 230000004888 barrier function Effects 0.000 claims description 61
- 239000000463 material Substances 0.000 claims description 42
- 239000011148 porous material Substances 0.000 claims description 17
- 230000000149 penetrating effect Effects 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 8
- 230000003993 interaction Effects 0.000 claims description 6
- 210000004881 tumor cell Anatomy 0.000 claims description 3
- 230000004060 metabolic process Effects 0.000 claims 2
- 210000004379 membrane Anatomy 0.000 description 129
- 239000000523 sample Substances 0.000 description 75
- 210000002993 trophoblast Anatomy 0.000 description 75
- 239000003153 chemical reaction reagent Substances 0.000 description 19
- 230000001965 increasing effect Effects 0.000 description 18
- 238000006073 displacement reaction Methods 0.000 description 17
- 230000007704 transition Effects 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- 239000010408 film Substances 0.000 description 16
- 239000007788 liquid Substances 0.000 description 16
- 238000011144 upstream manufacturing Methods 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 210000003754 fetus Anatomy 0.000 description 15
- 230000002062 proliferating effect Effects 0.000 description 15
- 210000000601 blood cell Anatomy 0.000 description 13
- 210000000265 leukocyte Anatomy 0.000 description 12
- 238000004891 communication Methods 0.000 description 11
- 230000007423 decrease Effects 0.000 description 11
- 210000003743 erythrocyte Anatomy 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 230000000717 retained effect Effects 0.000 description 11
- 210000001772 blood platelet Anatomy 0.000 description 10
- 238000001514 detection method Methods 0.000 description 10
- 210000000440 neutrophil Anatomy 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 239000011521 glass Substances 0.000 description 9
- 239000011159 matrix material Substances 0.000 description 9
- 210000001616 monocyte Anatomy 0.000 description 9
- 210000002593 Y chromosome Anatomy 0.000 description 8
- 239000000834 fixative Substances 0.000 description 8
- 230000001939 inductive effect Effects 0.000 description 8
- 230000033001 locomotion Effects 0.000 description 8
- 210000001766 X chromosome Anatomy 0.000 description 7
- 230000003466 anti-cipated effect Effects 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 150000002298 globosides Chemical class 0.000 description 7
- 230000005484 gravity Effects 0.000 description 7
- 210000002826 placenta Anatomy 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000005452 bending Methods 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- 230000009089 cytolysis Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 210000004700 fetal blood Anatomy 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 5
- 210000002469 basement membrane Anatomy 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 230000007717 exclusion Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 235000012431 wafers Nutrition 0.000 description 5
- 108090000565 Capsid Proteins Proteins 0.000 description 4
- 102100023321 Ceruloplasmin Human genes 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004252 chorionic villi Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000004899 motility Effects 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000001052 transient effect Effects 0.000 description 4
- 210000000251 trophoblastic cell Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000702617 Human parvovirus B19 Species 0.000 description 3
- 101710081079 Minor spike protein H Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000234 capsid Anatomy 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 210000001671 embryonic stem cell Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000009545 invasion Effects 0.000 description 3
- 238000003754 machining Methods 0.000 description 3
- 108010082117 matrigel Proteins 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 210000003463 organelle Anatomy 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 230000003169 placental effect Effects 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000002458 cell surface marker Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000004464 cereal grain Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 210000000267 erythroid cell Anatomy 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 150000002339 glycosphingolipids Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 210000002767 hepatic artery Anatomy 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000002440 industrial waste Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000005459 micromachining Methods 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- -1 polytetrafluoroethylenes Polymers 0.000 description 2
- 238000003793 prenatal diagnosis Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000001573 trophoblastic effect Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- 101150028074 2 gene Proteins 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 101710197665 Capsid protein VP2 Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001002170 Homo sapiens Glutamine amidotransferase-like class 1 domain-containing protein 3, mitochondrial Proteins 0.000 description 1
- 101000736367 Homo sapiens PH and SEC7 domain-containing protein 3 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 102100036231 PH and SEC7 domain-containing protein 3 Human genes 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102100033237 Pro-epidermal growth factor Human genes 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000009087 cell motility Effects 0.000 description 1
- 238000003320 cell separation method Methods 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- QLBHNVFOQLIYTH-UHFFFAOYSA-L dipotassium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [K+].[K+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O QLBHNVFOQLIYTH-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 230000001973 epigenetic effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003237 epithelioid cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003000 extruded plastic Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000012953 feeding on blood of other organism Effects 0.000 description 1
- 210000000604 fetal stem cell Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 102000057808 human HES1 Human genes 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000001001 laser micro-dissection Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000003593 megakaryocyte Anatomy 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 239000011146 organic particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010125 resin casting Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000007704 wet chemistry method Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/02—Investigating particle size or size distribution
- G01N15/0272—Investigating particle size or size distribution with screening; with classification by filtering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/491—Blood by separating the blood components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/087—Multiple sequential chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/08—Regulating or influencing the flow resistance
- B01L2400/084—Passive control of flow resistance
- B01L2400/086—Passive control of flow resistance using baffles or other fixed flow obstructions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Ecology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26491809P | 2009-11-30 | 2009-11-30 | |
| PCT/US2010/058172 WO2011066497A2 (en) | 2009-11-30 | 2010-11-29 | Methods and apparatus for segregation of particles, including segregation and proliferation of fetal and stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012006244A true MX2012006244A (es) | 2012-10-15 |
Family
ID=43332885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012006244A MX2012006244A (es) | 2009-11-30 | 2010-11-29 | Metodos y aparatos para segregacion de particulas, incluyendo segregacion y proliferacion de celulas fetales y celulas madre. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2507382A4 (ja) |
| JP (2) | JP2013511992A (ja) |
| CN (1) | CN102695804B (ja) |
| AU (1) | AU2010246381B2 (ja) |
| BR (1) | BR112012013034A2 (ja) |
| CA (1) | CA2782176C (ja) |
| MX (1) | MX2012006244A (ja) |
| WO (1) | WO2011066497A2 (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2587248A1 (en) * | 2011-10-25 | 2013-05-01 | Koninklijke Philips Electronics N.V. | Filtering particles from blood or other media |
| US9631179B2 (en) | 2013-03-15 | 2017-04-25 | Angle North America, Inc. | Methods for segregating particles using an apparatus with a size-discriminating separation element having an elongate leading edge |
| JP6660950B2 (ja) * | 2014-10-27 | 2020-03-11 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 高効率イメージングプラットフォーム |
| CN105176812B (zh) * | 2015-07-28 | 2017-10-03 | 浙江奥瑞健生物技术有限公司 | 一种干细胞球切割收集装置及干细胞球的切割分离传代方法 |
| WO2017031017A1 (en) * | 2015-08-18 | 2017-02-23 | National Health Research Institutes | A microfluidic hydrodynamic shuttling chip device for highthroughput multiple single cells capture |
| GB201704766D0 (en) * | 2017-01-05 | 2017-05-10 | Illumia Inc | System and methods for selective effluent collection |
| EP3561038A1 (en) * | 2018-04-24 | 2019-10-30 | Bayer AG | Cell separator |
| US11389799B2 (en) * | 2019-01-17 | 2022-07-19 | The Regents Of The University Of Michigan | Microfluidic device for size and deformability measurements and applications thereof |
| CN113454437B (zh) * | 2019-02-27 | 2024-03-15 | 京瓷株式会社 | 粒子分离器件以及粒子分离计测装置 |
| CN109810894B (zh) * | 2019-03-01 | 2022-06-10 | 长春理工大学 | 一种基于光诱导介电泳的群细胞三维结构操纵与构建系统及方法 |
| JP7502740B2 (ja) | 2019-07-23 | 2024-06-19 | 国立大学法人佐賀大学 | 剪断処理による微細藻類の外被破壊法及び外被破壊システム |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6008040A (en) * | 1995-07-07 | 1999-12-28 | Synosys, Inc. | Procedures for efficient separation of cells, cellular materials and proteins |
| US6783928B2 (en) * | 2001-07-17 | 2004-08-31 | Georgi Hvichia | Microstructures for cell proliferation assays and semen analysis |
| US7993908B2 (en) * | 2001-07-17 | 2011-08-09 | Parsortix, Inc. | Microstructure for particle and cell separation, identification, sorting, and manipulation |
| EP2359689B1 (en) * | 2002-09-27 | 2015-08-26 | The General Hospital Corporation | Microfluidic device for cell separation and use thereof |
| EP1671101A1 (en) * | 2003-10-03 | 2006-06-21 | Vrije Universiteit Brussel | Method and device for size-separating particles present in a fluid |
| CN102083997B (zh) * | 2008-04-23 | 2016-05-25 | 角度北美公司 | 用于分离颗粒的方法和设备 |
-
2010
- 2010-11-23 AU AU2010246381A patent/AU2010246381B2/en active Active
- 2010-11-29 JP JP2012541219A patent/JP2013511992A/ja active Pending
- 2010-11-29 MX MX2012006244A patent/MX2012006244A/es not_active Application Discontinuation
- 2010-11-29 CN CN201080060399.2A patent/CN102695804B/zh active Active
- 2010-11-29 EP EP10834005.0A patent/EP2507382A4/en not_active Withdrawn
- 2010-11-29 WO PCT/US2010/058172 patent/WO2011066497A2/en active Application Filing
- 2010-11-29 CA CA2782176A patent/CA2782176C/en active Active
- 2010-11-29 BR BR112012013034A patent/BR112012013034A2/pt not_active IP Right Cessation
-
2016
- 2016-06-01 JP JP2016109647A patent/JP2016208978A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2507382A2 (en) | 2012-10-10 |
| JP2016208978A (ja) | 2016-12-15 |
| JP2013511992A (ja) | 2013-04-11 |
| AU2010246381B2 (en) | 2013-08-15 |
| EP2507382A4 (en) | 2016-06-08 |
| BR112012013034A2 (pt) | 2016-10-04 |
| CN102695804A (zh) | 2012-09-26 |
| WO2011066497A3 (en) | 2011-11-17 |
| WO2011066497A2 (en) | 2011-06-03 |
| AU2010246381A1 (en) | 2010-12-16 |
| CA2782176A1 (en) | 2011-06-03 |
| CA2782176C (en) | 2015-10-06 |
| CN102695804B (zh) | 2014-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20180299425A1 (en) | Methods and Apparatus for Segregation of Particles | |
| AU2010246381B2 (en) | Methods and apparatus for segregation of particles | |
| US10416150B2 (en) | Microfluidic isolation of tumor cells or other rare cells from whole blood or other liquids | |
| JP6782998B2 (ja) | 装置 | |
| Tan et al. | Microdevice for the isolation and enumeration of cancer cells from blood | |
| Mach et al. | Microfluidic sample preparation for diagnostic cytopathology | |
| US8986944B2 (en) | Methods and compositions for separating rare cells from fluid samples | |
| US7993908B2 (en) | Microstructure for particle and cell separation, identification, sorting, and manipulation | |
| EP3008162B1 (en) | Method for separation of sporadic cells from body fluids, and apparatus for carrying out said method | |
| JP2011163830A (ja) | サイズ選択マイクロキャビティアレイを用いた循環腫瘍細胞の検出 | |
| US20150076049A1 (en) | Microfilter and apparatus for separating a biological entity from a sample volume | |
| WO2010080978A2 (en) | Pre-depletion of leukocytes in whole blood samples prior to the capture of whole blood sample components | |
| WO2008155398A1 (en) | Separation method of biological objects relative to their viscoelastic properties | |
| JPWO2016208713A1 (ja) | プレート | |
| WO2011028483A2 (en) | Methods and apparatus for segregation of particles, including additional sources of sample collection for separation of nucleated fetal cells | |
| TWM583855U (zh) | 具有不平整結構的微流道晶片及微流道結構 | |
| US20220323957A1 (en) | Particle separator system, materials, and methods of use | |
| WO2017068326A2 (en) | Filtration apparatus | |
| Algarni | Investigation and Characterization of MP Derived from Media Conditioned by Various Cancer Cell Lines and Their Effect on Human Umbilical Vein Endothelial Cells (HUVECs) Under Static and Flow Conditions | |
| TWM581592U (zh) | 具有彎曲流道的微流道晶片及微流道結構 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |